Predicting response to neuromodulators in refractory chronic cough: An interpretable machine learning approach
Therapeutic Advances in Respiratory Disease · 2026
DOI: 10.1177/17534666261487594 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Therapeutic Advances in Respiratory Disease, 2026. Verfasst von Li Zhang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory and Critical Care Medicine, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai, China. Hauptthemen laut MEDLINE: Chronic Cough, Machine Learning, Neurotransmitter Agents, Predictive Learning Models. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Young Scientists Fund of the National Natural Science Foundation of China, Project of Science and Technology Commission of Shanghai Municipality, Shanghai Sailing Program.
Abstract (Originalsprache)
Background
Neuromodulators (e.g., Gabapentin, Baclofen, and Flupentixol-melitracen) are widely prescribed for refractory chronic cough (RCC); however, heterogeneous treatment responses remain a significant challenge for optimal agent selection.
Objectives
This study aimed to develop an interpretable machine learning (ML) model to predict individual patient responses to these therapies.
Design
Single-center retrospective observational study.
Methods
This retrospective cohort study included 730 patients with RCC treated with neuromodulators from 2016 to 2023. We extracted comprehensive clinical data, including demographics, patient-reported outcomes, medication history, and laboratory findings. Six ML algorithms underwent rigorous hyperparameter tuning and 10-fold cross-validation. Model performance was evaluated using the area under the receiver operating characteristic curve (AUC), calibration and decision curve analysis (DCA). The optimal model was interpreted using SHapley Additive exPlanations (SHAP).
Results
The overall neuromodulator response rate was 56.8%. A 14-variable Random Forest (RF) model demonstrated the best performance, yielding a training AUC of 0.825 (95% CI: 0.785-0.865; calibration slope: 0.984) and a robust cross-validated AUC of 0.718 (95% CI: 0.655-0.765; calibration slope: 0.956). SHAP analysis demonstrated that pre-treatment cough severity, history of esophagitis, and specific gastroesophageal reflux-related symptoms scores were identified as the top predictive features associated with treatment outcomes. The free online clinical decision-support application was deployed.
Conclusion
We developed and internally validated an interpretable ML model capable of predicting neuromodulator efficacy in RCC. The integration of SHAP clarifies feature attributions to support individualized, data-driven treatment selection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Respiratory and Critical Care Medicine, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai, China.
- Department of Pulmonary and Critical Care Medicine, Tongji Hospital, School of Medicine, Tongji University, Shanghai, China.
ORCID-Profile: Li Zhang
Förderung
- Young Scientists Fund of the National Natural Science Foundation of China
- Project of Science and Technology Commission of Shanghai Municipality
- Shanghai Sailing Program
Zitieren
APA
Zhang, L., Aierken, A., Chen, Q., Qiu, Z., & Dong, R. (2026). Predicting response to neuromodulators in refractory chronic cough: An interpretable machine learning approach. Therapeutic Advances in Respiratory Disease. https://doi.org/10.1177/17534666261487594
Vancouver
Zhang L, Aierken A, Chen Q, Qiu Z, Dong R. Predicting response to neuromodulators in refractory chronic cough: An interpretable machine learning approach. Therapeutic Advances in Respiratory Disease. 2026. doi:10.1177/17534666261487594
BibTeX
@article{Zhang2026,
author = {Zhang, Li and Aierken, Alimire and Chen, Qiang and Qiu, Zhongmin and Dong, Ran},
title = {Predicting response to neuromodulators in refractory chronic cough: An interpretable machine learning approach},
journal = {Therapeutic Advances in Respiratory Disease},
year = {2026},
doi = {10.1177/17534666261487594}
}
EUVIMED